Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Development of New Treatments for Cardiovascular Disease using Clinical Artificial Intelligence
31. Juli 2019 07:00 ET
|
Sensyne Health
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse...
Sensyne Health and the University of Oxford’s Big Data Institute to establish world-leading research alliance using data science and clinical AI for the patient-centred management and treatment of chronic disease
28. Januar 2019 07:01 ET
|
Sensyne Health
Sensyne Health and the University of Oxford’s Big Data Institute to establish world-leading research alliance using data science and...
Sensyne Health signs agreement with Jefferson Health to evaluate the clinical and commercial potential of GDm-Health™ in the United States
28. Januar 2019 07:01 ET
|
Sensyne Health
Sensyne Health signs agreement with Jefferson Health to evaluate the clinical and commercial potential of GDm-Health™ in the United States Entry to US market grows Sensyne Health database on...
Sensyne Health and Wye Valley NHS Trust sign Strategic Research Agreement
28. Januar 2019 07:01 ET
|
Sensyne Health
Sensyne Health and Wye Valley NHS Trust signStrategic Research Agreement New agreement provides access to anonymised patient datasets covering 1.36 million hospital admissions, for analysis using...
Sensyne Health and George Eliot Hospital NHS Trust sign Strategic Research Agreement
28. Januar 2019 07:01 ET
|
Sensyne Health
Sensyne Health and George Eliot Hospital NHS Trust signStrategic Research Agreement New agreement provides access to anonymised patient datasets covering 746,000 hospital admissions, for analysis...
Sensyne Health Maiden Interim Results 2018
28. Januar 2019 07:00 ET
|
Sensyne Health
Sensyne Health Maiden Interim Results 2018 Strong progress in first period as a public company Oxford, UK; 28 January 2019: Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the...